Transaction | Address | Amount |
---|---|---|
0xb366...0346f7
|
0x291d...22ead9
|
-
4,339.532232757296344874 RWA
|
0xb366...0346f7
|
0x4448...00e110
|
+
4,339.532232757296344874 RWA
|
0xb366...0346f7
|
0x291d...22ead9
|
-
0.022946783298494704 WETH
·
89.09 USD
|
0xb366...0346f7
|
0x24bf...ecb250
|
+
0.022946783298494704 WETH
·
89.09 USD
|
0x869c...bb7928
|
0x9b14...11e606
|
-
22,282.435665785968577032 GLS
|
0x869c...bb7928
|
0xf5b6...41179c
|
+
22,282.435665785968577032 GLS
|
0x869c...bb7928
|
0x3328...309c49
|
-
0.199004975124378109 WETH
·
772.66 USD
|
0x869c...bb7928
|
0x9b14...11e606
|
+
0.199004975124378109 WETH
·
772.66 USD
|
0xe887...6fb6c7
|
0x94f0...a6e960
|
-
0.130055078325670928 WETH
·
504.95 USD
|
0xe887...6fb6c7
|
0xb154...2081b3
|
+
0.130055078325670928 WETH
·
504.95 USD
|
BitMine opts for a $1 billion share repurchase plan, prioritizing buybacks over increasing its Ethereum holdings, as its stock trades below net asset value.
Abraxas Capital faces $100M in unrealized losses on $800M crypto shorts amidst a bullish market.
180 Life Sciences pivots to crypto with a $425 million investment in Ethereum, aiming to become "ETHZilla" and create the largest corporate ETH treasury.